SRC
OPK icon

Shufro Rose & Co’s Opko Health OPK Stock Holding History

Shufro Rose & Co’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,000
Closed -$20K – 317
2020
Q4 		$20K Buy
+5,000
New +$20.9K ﹤0.01% 288

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shufro Rose & Co's OPK Position: Q1 2026 in Review

Shufro Rose & Co held its Opko Health (OPK) position steady in Q1 2026 at 17,000 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Shufro Rose & Co first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.87M in Q3 2016. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Shufro Rose & Co held 17,000 shares of Opko Health worth $19.4K as of Q1 2026.
  • Shufro Rose & Co left its Opko Health share count unchanged in Q1 2026.
  • Opko Health made up ﹤0.01% of Shufro Rose & Co's portfolio in Q1 2026, its #307 holding.
  • Shufro Rose & Co first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • Shufro Rose & Co's Opko Health position peaked at $1.87M in Q3 2016.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.